Based on our observation that the cellular morphology of prostate cancer cells was disturbed following GSK-3β inhibition and a previous study pointing out a link between GSK-3β and F-actin [23], we performed a DAPI/Phalloidin double staining to monitor F-actin polymerization. The gene discussed is GSK3B; the disease is prostate carcinoma.